Cefuroxime Axetil Dosing for Acute Cystitis
For acute uncomplicated cystitis, cefuroxime axetil (Ceftin) should be dosed at 250 mg orally twice daily for 3-7 days when other recommended first-line agents cannot be used. 1, 2
Recommended Treatment Algorithm for Acute Cystitis
First-Line Options (Preferred over Cefuroxime)
- Nitrofurantoin 100 mg twice daily for 5 days due to minimal resistance and limited collateral damage 1
- Trimethoprim-sulfamethoxazole 160/800 mg twice daily for 3 days if local resistance rates are <20% 1
- Fosfomycin trometamol 3 g single dose where available 1
Second-Line Options (When First-Line Cannot Be Used)
- β-Lactams including cefuroxime axetil 250 mg twice daily for 3-7 days 1, 2, 3
- Other β-lactams such as cefpodoxime proxetil 100 mg twice daily for 3 days 1, 4
- Fluoroquinolones (e.g., ciprofloxacin 250 mg twice daily for 3 days) should be reserved due to concerns about resistance and collateral damage 1
Rationale for Cefuroxime Axetil Recommendation
- β-Lactams generally have inferior efficacy and more adverse effects compared to first-line agents for uncomplicated cystitis 1
- Clinical studies show cefuroxime axetil can be effective for uncomplicated UTIs with cure rates of 93-95% 3
- The FDA-approved dosing for cefuroxime in uncomplicated urinary tract infections is consistent with the recommendation of 250 mg twice daily 2
Important Considerations
β-Lactams should be used with caution for uncomplicated cystitis due to:
Obtain urine culture before starting therapy if:
- Patient has risk factors for resistant organisms
- Previous treatment failure
- Recurrent UTI 1
Common adverse effects of cefuroxime axetil include:
Clinical Pitfalls to Avoid
- Do not use amoxicillin or ampicillin for empirical treatment due to poor efficacy and high resistance rates 1
- Do not extend treatment beyond 7 days for uncomplicated cystitis as longer durations increase risk of adverse effects without improving outcomes 1
- Avoid fluoroquinolones as first-line therapy despite high efficacy due to concerns about promoting resistance and potential association with MRSA 1
- Remember that cefuroxime and other β-lactams should only be used when first-line agents cannot be used (e.g., allergy, resistance, or unavailability) 1